Stacey Johnson
Stacey Johnson is the editor of Signals and a contributor. For 25 years, Stacey has been providing strategic communications counsel to government, corporate, technology and health organizations. She began her career at the CTV Television Network and then moved to Hill & Knowlton Canada where she advised clients in a variety of industries and sectors. Stacey is the Vice President, Communications and Marketing for CCRM, a leader in developing and commercializing regenerative medicine-based technologies and cell and gene therapies. She has a Master's degree in Public Relations. You can follow her on Twitter @msstaceyerin.
Posts by: Stacey
Right Turn: Beyond the ’stache: The science, the progress, the promise
For some, it happens overnight. For others, it takes weeks of nurturing and coaxing. But most of them get there in the end. A quick glance at the calendar tells you exactly what I mean: Movember is back —the one month of the year when upper lips everywhere decide to come out of hibernation. It’s […]
Right Turn: Some takeaways from Advanced Therapies Week 2025
In a new location, with highways replacing waterways, it’s comforting to have an agenda with some consistent touchpoints for familiarity, and Advanced Therapies Week 2025 (ATW25), January 20-23 in Dallas, Texas, began with two of my favourites: the Super plenary, moderated by Anthony Davies, Dark Horse Consulting Group, and the Opening plenary, featuring Susan Nichols, […]
Right Turn: Stem cell supplements: A growing market with growing risks
A recent publication on the marketing of stem cell supplements, in the International Society for Stem Cell Research’s (ISSCR) Stem Cell Reports, sparked my curiosity about these products. While I haven’t been able to find a reliable source indicating how long stem cell supplements have been around, they are being marketed to enhance stem cell […]